Gemcitabine-loaded ICOS-Fc decorated nanosponges: A new chemo immunotherapy combination against pancreatic cancer

This publication has 72 references indexed in Scilit:

• Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models
  Advanced Science, 2023
• Errors in Figure 1
  JAMA Oncology, 2022
• 3D Human Tumor Tissues Cultured in Dynamic Conditions as Alternative In Vitro Disease Models
  2022
• Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
  JAMA Network Open, 2022
• A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models
  Pharmaceutical Research, 2021
• KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK–ERK pathway in pancreatic cancer
  International Journal of Cancer, 2018
• Chitosan-Alginate Scaffold Culture System for Hepatocellular Carcinoma Increases Malignancy and Drug Resistance
  Pharmaceutical Research, 2010
• PHARMACOKINETICS OF DOXORUBICIN INCORPORATED IN SOLID LIPID NANOSPHERES (SLN)
  Pharmacological Research, 1999
• Characterization of H4: a mouse T lymphocyte activation molecule functionally associated with the CD3/T cell receptor
  European Journal of Immunology, 1996
• Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair
  International Journal of Pharmaceutics, 1995